TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
RVMD

Revolution Medicines Inc

Healthcare · Biotechnology

205.00$ +2.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow RVMD
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – -4,190.4% – – – – – –
– +48.5% +89.5% +95.8% +12.0% +31.7% -3.6% +27.0% -328.0%
– +506.4% +269.7% +181.1% +133.2% +50.5% +98.0% +28.2% +49.5%
– +2,153.2% +11.2% +140.8% +180.3% +18.0% – – –
– +718.5% -111.7% – – -254.6% – -97.1% +7,333.5%
– -4.8% +72.7% +13.3% +122.6% +65.7% -28.5% +33.4% +55.1%
– -15.0% +7,515.3% +129.7% -39.3% -83.0% +1,320.6% +61.8% –
– -100.6% -65.6% – +125.4% -0.6% +78.0% +51.6% +59.8%
– +168.5% +62.1% +328.5% -30.4% +2.5% +307.8% -21.9% -35.2%
– – -187.2% – -94.5% +983.9% +910.6% -128.6% –
– – – – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?